Woodline Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Woodline Partners’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-267,540	Closed	-$13.8M	–	979
2022 Q3	$13.8M	Buy	+267,540	New	+$11.1M	0.19%	154
2022 Q2	–	Sell	-203,093	Closed	-$5.09M	–	928
2022 Q1	$5.09M	Buy	203,093 +54,798	+37%	+$1.54M	0.08%	242
2021 Q4	$5.4M	Buy	+148,295	New	+$5.21M	0.08%	274

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Woodline Partners's CCXI Position: Q4 2022 in Review

Woodline Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 267,540 shares — an estimated $13.8M sold.

Woodline Partners first reported a position in CCXI in Q4 2021 and held it in 3 quarters. The position peaked at $13.8M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Woodline Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Woodline Partners sold 267,540 ChemoCentryx, Inc. shares in Q4 2022, an estimated $13.8M.
Woodline Partners first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 3 quarters.
Woodline Partners's ChemoCentryx, Inc. position peaked at $13.8M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Woodline Partners's 13F filing for Q4 2022, filed 14 Feb 2023.